Raymond James & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$25.6M Sell
176,121
-13,645
-7% -$1.99M 0.02% 693
2024
Q2
$26M Buy
189,766
+7,931
+4% +$1.09M 0.02% 654
2024
Q1
$25M Buy
181,835
+9,073
+5% +$1.24M 0.02% 677
2023
Q4
$23.5M Sell
172,762
-15,732
-8% -$2.14M 0.02% 667
2023
Q3
$23.1M Sell
188,494
-3,808
-2% -$466K 0.02% 616
2023
Q2
$24.4M Sell
192,302
-10,869
-5% -$1.38M 0.02% 611
2023
Q1
$26.2M Buy
203,171
+5,799
+3% +$749K 0.02% 578
2022
Q4
$25.9M Buy
197,372
+17,857
+10% +$2.34M 0.02% 557
2022
Q3
$21M Buy
179,515
+26,224
+17% +$3.07M 0.02% 601
2022
Q2
$18M Sell
153,291
-17,502
-10% -$2.06M 0.02% 668
2022
Q1
$22.3M Sell
170,793
-11,697
-6% -$1.52M 0.02% 645
2021
Q4
$27.9M Sell
182,490
-1,953
-1% -$298K 0.02% 592
2021
Q3
$29.8M Buy
184,443
+12,630
+7% +$2.04M 0.03% 522
2021
Q2
$28.1M Sell
171,813
-15,846
-8% -$2.59M 0.03% 543
2021
Q1
$28.3M Sell
187,659
-29,886
-14% -$4.5M 0.03% 514
2020
Q4
$33M Buy
217,545
+18,724
+9% +$2.84M 0.04% 416
2020
Q3
$26.9M Sell
198,821
-9,753
-5% -$1.32M 0.03% 437
2020
Q2
$28.5M Buy
208,574
+66,289
+47% +$9.06M 0.04% 390
2020
Q1
$15.3M Sell
142,285
-30,061
-17% -$3.24M 0.02% 553
2019
Q4
$20.8M Buy
172,346
+21,102
+14% +$2.54M 0.03% 563
2019
Q3
$15M Sell
151,244
-36,857
-20% -$3.67M 0.02% 672
2019
Q2
$20.5M Sell
188,101
-17,114
-8% -$1.87M 0.03% 526
2019
Q1
$22.9M Sell
205,215
-3,120
-1% -$349K 0.03% 470
2018
Q4
$20.1M Sell
208,335
-52,828
-20% -$5.09M 0.04% 471
2018
Q3
$31.8M Buy
261,163
+26,921
+11% +$3.28M 0.05% 362
2018
Q2
$25.7M Sell
234,242
-50,156
-18% -$5.51M 0.04% 405
2018
Q1
$30.4M Buy
284,398
+5,780
+2% +$617K 0.05% 326
2017
Q4
$29.8M Buy
278,618
+26,303
+10% +$2.81M 0.05% 329
2017
Q3
$28.1M Buy
252,315
+19,878
+9% +$2.21M 0.06% 322
2017
Q2
$24M Buy
232,437
+46,932
+25% +$4.85M 0.05% 350
2017
Q1
$18.1M Sell
185,505
-115,275
-38% -$11.3M 0.04% 431
2016
Q4
$26.6M Buy
300,780
+46,671
+18% +$4.13M 0.07% 284
2016
Q3
$24.5M Buy
254,109
+119,511
+89% +$11.5M 0.07% 286
2016
Q2
$11.5M Buy
134,598
+48,363
+56% +$4.15M 0.04% 487
2016
Q1
$7.5M Sell
86,235
-70,704
-45% -$6.15M 0.03% 636
2015
Q4
$17.7M Sell
156,939
-12,339
-7% -$1.39M 0.06% 333
2015
Q3
$17.1M Sell
169,278
-12,627
-7% -$1.28M 0.07% 304
2015
Q2
$22.4M Buy
181,905
+906
+0.5% +$111K 0.09% 270
2015
Q1
$20.7M Buy
180,999
+28,632
+19% +$3.28M 0.09% 244
2014
Q4
$15.4M Buy
152,367
+77,583
+104% +$7.85M 0.08% 288
2014
Q3
$6.82M Sell
74,784
-11,970
-14% -$1.09M 0.04% 491
2014
Q2
$7.43M Buy
86,754
+9,195
+12% +$788K 0.05% 456
2014
Q1
$6.11M Buy
77,559
+14,754
+23% +$1.16M 0.04% 488
2013
Q4
$4.75M Buy
62,805
+3,840
+7% +$291K 0.04% 555
2013
Q3
$4.12M Buy
58,965
+8,508
+17% +$594K 0.04% 551
2013
Q2
$2.93M Buy
+50,457
New +$2.93M 0.03% 636